Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.385, 2002-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
MS poses substantial employer burden
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 588, 2009-01 ,pp. :
Access to resources
Recommend
Musculoskeletal disorders: substantial economic burden
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 323, 2001-01 ,pp. :
Recognition of bipolar disorder relieves substantial cost burden
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 442, 2003-01 ,pp. :
Economic burden of MRSA-related NP substantial
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 668, 2012-01 ,pp. :
Substantial burden imposed by enteroviral meningitis in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 301, 2001-01 ,pp. :